INDEGENE
Back to Income Statement
|
INDEGENE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,839 Cr | ₹2,590 Cr | ₹2,306 Cr | ₹1,665 Cr | ₹966 Cr |
What is the latest Revenue of INDEGENE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,839 Cr |
| Mar2024 | ₹2,590 Cr |
| Mar2023 | ₹2,306 Cr |
| Mar2022 | ₹1,665 Cr |
| Mar2021 | ₹966 Cr |
How is Revenue of INDEGENE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,839 Cr | 9.64 | |
| Mar2024 | ₹2,590 Cr | 12.29 | |
| Mar2023 | ₹2,306 Cr | 38.54 | |
| Mar2022 | ₹1,665 Cr | 72.27 | |
| Mar2021 | ₹966 Cr | - | |
Compare Revenue of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,624.6 Cr | -2.9% | 2% | -16% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -2.9% |
2% |
-16% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses